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ABSTRACT We have examined the effect on respiration of
the steroid hormone progesterone, administered either intra-
venously or directly into the medulla oblongata in anesthetized
and paralyzed male and female cats. The carotid sinus and
vagus nerves were cut, and end-tidal Pco2 and temperature
were kept constant with servo-controllers. Phrenic nerve
activity was used to quantitate central respiratory activity.
Repeated doses of progesterone (from 0.1 to 2.0 ,ug/kg,
cumulative) caused a sustained (>45 min) facilitation of
phrenic nerve activity in female and male cats; however, the
response was much more variable in females. Progesterone
injected into the region of nucleus tractus solitarii, a respira-
tory-related area in the medulla oblongata, also caused a
prolonged stimulation of respiration. Progesterone adminis-
tration at high concentration by both routes also caused a
substantial hypotension. Identical i.v. doses of other classes of
steroid hormones (17f8-estradiol, testosterone, and cortisol) did
not elicit the same respiratory effect. Pretreatment with RU
486, a progesterone-receptor antagonist, blocked the facilita-
tory effect of progesterone. We conclude that progesterone acts
centrally through a steroid receptor-mediated mechanism to
facilitate respiration.
It has been known since the turn of the century that women
hyperventilate during pregnancy (1, 2) and during the luteal
phase of the menstrual cycle (3). Because the level of
circulating progesterone correlates positively with increased
ventilation, progesterone has been proposed as the ventila-
tory stimulant in these conditions (4)-a contention further
supported by studies in which exogenously administered
progesterone caused hyperventilation in normal male sub-
jects (5, 6) and in patients with breathing disorders (7-12).
Even though many animal species hyperventilate during
pregnancy when endogenous progesterone levels are elevat-
ed (13-15), most fail to respond in a like manner to exoge-
nously administered progesterone under experimental con-
ditions (5, 15-17). Such data has been interpreted to mean
that progesterone is not the respiratory stimulant during
pregnancy and the luteal phase of the menstrual cycle.
However, a reasonable explanation exists for this apparent
discrepancy. Estrogen levels increase during pregnancy, and
estrogen causes induction, or upregulation, of progesterone
receptors within certain regions of the brain (18, 19). Thus,
progesterone released endogenously during pregnancy would
be expected to elicit a greater response than exogenously
administered progesterone to animals not pretreated with
estrogen. Furthermore, a mild stimulation of respiration
induced by exogenous progesterone could possibly have
been obscured by concomitant hypocapnia and negative
respiratory feedback.
Therefore, to properly characterize the effect of exoge-
nously administered progesterone on respiration the studies
must be done in animals where respiratory feedback mech-
anisms have been either eliminated or controlled. Under such
conditions we show progesterone to be a powerful respira-
tory stimulant. That a specific steroid receptor mechanism
mediates the facilitatory effect of progesterone on respiration
is also supported by our data.
MATERIALS AND METHODS
Studies were done on 18 female and 12 male adult cats. All
were anesthetized i.v. with chloralose (40 mg/kg) and ure-
thane (240 mg/kg); because this combination provides a
long-lasting anesthesia (20), no further anesthetic was ad-
ministered during the study. Femoral arterial pressure was
measured with a strain gauge. Temperature was monitored
with a rectal thermistor and maintained at 370C by an
electronic servo-control circuit and dc heating pad. The
trachea was cannulated, and airway PCO2 was measured with
an infrared CO2 analyzer.
Respiratory feedback from the arterial chemoreceptors
and the pulmonary mechanoreceptors was blocked by cutting
the carotid sinus and vagus nerves. A dorsal laminectomy
was performed in one cat, and the spinal cord was transected
at C7/T1 to eliminate input from visceral or somatic recep-
tors. One phrenic nerve root (C5) was exposed, cut distally,
desheathed, and placed in a bipolar platinum recording
electrode that was built into a small acrylic platform placed
in a tissue well adjacent to the nerve. Because the electrode
had no fixed external attachments (the electrical wires were
flexible and moved freely), it was possible, even during a long
experiment, to maintain a relatively constant electrical cou-
pling between nerve and electrode. In two cats dorsal
craniotomies were performed, and the dura were removed to
expose the dorsal surface of the medulla oblongata. Bleeding
was controlled with Gelfoam and bone wax.
All animals were paralyzed with gallamine triethiodide (3
mg/kg initially followed by a continuous infusion at a rate of
3 mg/kg per hr) and ventilated artificially with 100% 02. To
prevent significant changes in end-tidal and arterial CO2
secondary to changes in metabolism, the dc voltage on the
motor of the ventilator was controlled by the animal's
end-tidal PCO2 through an electronic circuit (21). The pump-
ing frequency of the ventilator was thereby servo-controlled
to maintain arterial PCO2 constant throughout an experiment.
Reagents. Progesterone (4-pregnen-3,20-dione), 17,B-estra-
diol [1,3,5,(10)-estratriene-3,17,B-diol], testosterone (17,3-hy-
droxy-4-androsten-3-one), and cortisol (11,8,17,21-trihy-
droxy-4-pregnene-3,20-dione) were obtained from Steraloids
(Wilton, NH). RU 486 [17f3-hydroxy-11p-(4-dimethylamino-
phenyl)-17a-(1-propynyl)estra-4,9-dione-3-one] was provid-
ed by R. Deraedt at the Centre de Recherches Roussel-Uclaf
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(Romainville, France). The weighed hormone was dissolved
in =0.3 ml of 95% ethyl alcohol and diluted to 1 ml with
Ringer's solution.
Experimental Protocol. Hormone administration was de-
layed for at least 1 hr after completion of surgery. When all
variables had stabilized, control values for phrenic nerve
activity, arterial pressure, and end-tidal Pco2 were recorded
for 3 min. Repeated doses of progesterone (0.1, 0.2, 0.5, 1.0,
and 2.0,g/kg, cumulative) were then administered i.v. to 17
female and 9 male cats. The effect on phrenic activity and
arterial pressure of each dose was followed for 45 min, with
measurements being made at intervals of 5 min. Two male
cats were pretreated with RU 486, a competitive antagonist
for the progesterone receptor (22), 1 hr before receiving the
first progesterone dose. Three additional male cats each
received repeated doses of either 17p8-estradiol, testosterone,
or cortisol following the same dose regime.
A micropipette (tip diameter 15-25 pum) containing either
10 mM or 1 p.M progesterone was placed stereotaxically into
the region of nucleus tractus solitarii in two cats. Injections
were made by applying pressure to the micropipette via
flexible tubing attached to a nitrogen pressure source. The
volume of fluid injected was determined by measuring the
displacement of the meniscus in the micropipette using a
monocular microscope fitted with a graticule.
Data Analysis. Data on phrenic nerve activity, arterial
pressure, and airway Pco2 were all recorded on magnetic
tape. Phrenic nerve activity was rectified and integrated for
each 100 msec. The highest level of activity during a phrenic
burst (peak activity) is the neural equivalent of tidal volume
(23). Phrenic minute activity is calculated as the product of
peak phrenic activity and respiratory rate.
Phrenic activity was normalized by assigning a value of 100
units to the level of phrenic activity in each cat that corre-
sponded to an increase in end-tidal Pco2 of 40 torr (1 torr =
133 Pa) above apneic threshold (24); all other levels were
scaled accordingly. Analyses of significance of differences
were done using one-way analysis of variance for repeated
measures. Differences from control were analyzed using
Dunnett's test and were considered significant at the P < 0.05
level.
RESULTS
Fig. 1 shows the effect on integrated phrenic nerve activity
and arterial pressure in one female cat of repeated i.v. doses
of progesterone. Measurements were made at 45 min after
each dose. Peak phrenic (tidal) activity increased with each
dose up to a cumulative dose of 1.0 ,gg/kg; an additional 1.0
,pg/kg of progesterone elicited no further increase. Cumula-
tive doses of progesterone in excess of 0.5 uxg/kg caused a
substantial hypotension (-30 mm Hg).
The effect on minute phrenic activity in 17 female and 6
male cats of repeated i.v. doses of progesterone are shown in
Fig. 2. Again, measurements (change from control) were
made 45 min after each dose. End-tidal Pco2 and temperature
were kept constant in each animal throughout the experi-
ment. At the highest dose (2.0 pg/kg) progesterone facilitated
phrenic nerve activity in 12 of 17 female cats studied; four
cats showed a slight inhibition, and in one cat minute phrenic
activity was unchanged from control level (Fig. 2A). Most
striking, however, was the high degree of variability espe-
cially evident after the highest dose. Intravenously adminis-
tered progesterone facilitated respiration in all six male cats
(Fig. 2B). Responses were noticeably more consistent than
those measured in the female group.
Averaged findings for phrenic activity and arterial pressure
in the female and male groups, as well as statistical results,
are given in Table 1. Despite variability differences, magni-
tude of the stimulation of phrenic nerve activity after each
progesterone dose was essentially the same for both female
and male groups. Another interesting finding was that a
sustained decrease in arterial pressure was measured with
increasing doses of progesterone in both groups.
To rule out the possibility that the facilitatory effect of
progesterone on phrenic nerve activity was mediated by a
somatic or visceral afferent pathway, one male cat was
studied after transection of the spinal cord at C7/T1. Phrenic
nerve response to i.v. administered progesterone in this cat
was not different than that measured in cats with intact spinal
cords.
Fig. 3 shows the effect on integrated phrenic nerve activity
and arterial pressure of an injection of 0.9 p.l of 1.0 p.M (0.9
pmol) progesterone into the region of nucleus tractus solitarii
in one cat. End-tidal Pco2 was maintained at 29 torr. A small
increase in phrenic activity was recorded within 15 min after
hormone injection. Substantial increases occurred during the
subsequent 30 min (i.e., 30 and 45 min after injection). Mean
arterial pressure decreased from 85 mm Hg during control to
-65 mm Hg at 45 min after progesterone injection. These
responses were similar to those measured following i.v.
administration of progesterone (Fig. 1, Table 1). An almost
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FIG. 1. Effect on arterial pressure and integrated phrenic nerve activity of progressive i.v. progesterone administration. End-tidal Pco2 was
held constant at 32 torr.
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FIG. 2. Respiratory responses (change in minute phrenic activity) to progressive i.v. progesterone administration in individual female (A;
n = 17) and male (B; n = 6) cats. End-tidal Pco2 was held constant in all experiments.
in which a smaller volume (0.1 pl) of more concentrated
progesterone (0.01 M; 1.0 nmol) was injected.
To determine whether the facilitatory effect of progester-
one on respiration was mediated by a steroid receptor
mechanism, two approaches were used. (i) Phrenic nerve
response to other steroid hormones was determined. (ii)
Respiratory response to progesterone after pretreatment with
RU 486 was measured. Findings from these experiments are
shown in Fig. 4, where the shaded area represents the range
of respiratory responses to repeated doses of i.v. adminis-
tered progesterone measured in six male cats (see Fig. 2B).
Both cortisol and 17,8-estradiol caused minor stimulation of
phrenic activity by the final dose, but this increase was
considerably less than the smallest response recorded during
i.v. administration ofprogesterone (i.e., lower edge ofshaded
area). Testosterone substantially inhibited phrenic activity.
The stimulation of respiration elicited by progesterone is
evidently not due to a nonspecific steroid effect. Two
additional male cats were pretreated with RU 486 at least an
hour before progesterone administration. RU 486 had only a
small, transient inhibitory effect on respiration that lasted for
several minutes. Progesterone was not administered until all
variables had become stable. Repeated doses ofprogesterone
then caused inhibition of phrenic activity rather than the
customary stimulation observed in untreated animals. In fact,
both cats pretreated with RU 486 developed apnea at a
cumulative dose of 1.0 to 2.0 pg/kg. That the stimulation of
respiration elicited by progesterone was found to be proges-
terone specific and that RU 486 antagonized the response
implicate involvement of a receptor mechanism.
DISCUSSION
We have studied the effect on respiration of exogenously
administered progesterone; we found that progesterone ad-
ministered intravenously at physiological concentrations
caused prolonged (>45 min) stimulation of respiration in all
male cats and in 12 of 17 female cats studied. Instability ofthe
preparation is unlikely to account for these findings because
of the long-lasting nature of the anesthesia and the stable
coupling between nerve and electrode. Moreover, in a
separate study we found that in the absence of intervention
Table 1. Mean data (±SEM) from male (d) and female (9) cats during control and at 45 min after each i.v. progesterone dose
Progesterone, pg/kg
Control 0.1 0.2 0.5 1.0 2.0
d 9 9 9 9 9 9
Number (n) 6.0 17.0 6.0 17.0 5.0* 16.Ot 5.0* 17.0 6.0 17.0 6.0 17.0
Respiratory rate, 18.3 17.4 20.1 19.1 22.9 19.8 25.7 20.4 23.1 21.1 19.7 20.8
breaths/min ±1.9 ±1.7 ±0.9 ±1.7 ±0.6t ± 1.6 ±2.3§ + 1.6 ± 1.0t ± 1.6t ± 1.2 ±1.6
Phrenic tidal activity, 23.2 23.9 26.5 27.1 32.2 32.1 38.8 32.9 47.0 36.7 50.8 40.1
units ±1.6 ±1.4 ±2.6 ±2.5 ±3.2 ±3.5 +6.8§ ±3.7 ±6.9§ +4.6 +7.2§ ±5.9*
Phrenic minute activity, 20.4 24.0 26.7 31.0 35.8 39.9 46.2 40.4 52.3 51.4 47.8 56.9
units/min ±1.8 ±1.1 ±4.2 ±3.4 ±5.1§ ±5.7 ±6.5§ ±5.6 ±6.8§ +9.9t +5.8§ ±12.3*
MAP, mm Hg 122.2 115.6 119.7 110.5 119.0 99.9 116.8 100.6 108.2 97.5 105.0 91.4
±12.3 ±3.9 ±11.4 ±3.9 ±12.9 ±4.4 ±12.6 ±4.4 ±10.5t +4.8t +9.1t +4.5§
MAP, mean arterial pressure.
*Missing data due to equipment malfunction.
tMissing data due to missed injection.
tSignificantly different from control at P < 0.05.
§Significantly different from control at P < 0.01.
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TIME AFTER INJECTION (min)
45
FIG. 3. Effect on arterial pressure and integrated phrenic nerve activity of a pressure injection of 0.9 pd of 1.0 ,uM (0.9 pmol) progesterone
into the dorsal medulla. End-tidal Pco2 was held constant at 28.5 torr.
all measured variables remained stable over an extended
period (>6 hr, unpublished observations).
End-tidal Pco2 was kept constant in these animals, and
respiratory feedback from peripheral chemoreceptors and
lung mechanoreceptors was eliminated. In addition, in one
animal, afferent input from visceral and somatic receptors
was also eliminated. Because these peripheral feedback
mechanisms were not necessary for the progesterone-in-
duced respiratory facilitation, we conclude that a central
nervous system mechanism is involved in the response. [We
must emphasize that this does not preclude a role for certain
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FIG. 4. Comparison of the change in minute phrenic activity with
progesterone administration (shaded area is the range of findings
from Fig. 2B) to the i.v. administration of the other steroids (o,
cortisol; o, 17,p-estradiol; A, testosterone) and to the response to
progesterone after pretreatment with RU 486 (o) in male cats.
End-tidal Pco2 was maintained constant in all experiments.
in the overall response of the intact animal to progesterone.]
Furthermore, microinjection ofprogesterone directly into the
region of nucleus tractus solitarii, an area in the medulla
oblongata associated with respiration (25), caused a similar
enhancement of phrenic nerve activity. Thus, progesterone
may act directly on medullary neurons to enhance respira-
tion.
This facilitatory effect of exogenously administered pro-
gesterone on respiration could not be mimicked with other
classes of steroid hormones and was blocked in animals that
were pretreated with RU 486, a progesterone-receptor an-
tagonist (22). We conclude, therefore, that this facilitation is
receptor mediated. Moreover, we have shown that after
pretreatment with RU 486, repeated doses of progesterone
caused progressive inhibition, rather than facilitation, of
phrenic nerve activity. The mechanism of this inhibition is
unknown.
In our studies, 17f3-estradiol and cortisol only slightly
facilitated phrenic activity; testosterone substantially inhib-
ited phrenic activity. Other workers have found that exoge-
nously administered estradiol has no effect on respiration in
either human subjects (26, 27) or rats (16). Koepchen (28)
reported that exogenously administered testosterone had no
acute effects on ventilation. However, because men seem
more prone than women to develop apneas (29) and because
elevated testosterone levels may be involved in the etiology
of obesity hypoventilation syndrome (30), the inhibitory
effect of testosterone that we report may be a significant
finding that warrants further study.
No attempt was made to control the levels of endogenous
estrogen or progesterone in the present study-i.e., castra-
tion and pretreatment with hormone. Instead we studied
intact female cats that were chosen randomly from our animal
holding facility. The individual female cats, therefore, may
have been at different states of estrous and consequently had
different levels of these hormones at the time of study. We
believe these differences best account for the high degree of
variability of respiratory response to progesterone. Endog-
enous progesterone would affect the response to exogenous
progesterone by competing for the receptor. The effect of
estrogen on the response to progesterone is through its ability
to induce progesterone receptors in certain regions of the
central nervous system (18, 19). Thus, we speculate that the
greatest response to exogenous progesterone occurred in
female cats at a time after induction of progesterone recep-
tors by estrogen but while endogenous progesterone concen-
trations were low. Mild stimulation could have resulted when
Physiological Sciences: Bayliss et al. 7791
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exogenous progesterone was allowed only limited access to
the receptor, either because of competition with endogenous
progesterone, or because ofa lower receptor density. Finally,
the inhibition noticed in four female cats might have resulted
from administering progesterone when most receptor sites
were occupied by endogenous progesterone.
An unexpected finding was that repeated i.v. doses of
progesterone caused a progressive decrease in mean arterial
pressure in both female and male cats. Because injection of
progesterone directly into the dorsal aspect of the medulla
oblongata also caused a substantial hypotension, we believe
that progesterone may have an inhibitory effect on central
nervous system neurons involved in control ofthe circulation at
high concentrations.
We present evidence that progesterone stimulates respira-
tion centrally through a steroid receptor-mediated mecha-
nism. We conclude that progesterone is, indeed, the stimu-
lant that causes hyperventilation during the luteal phase of
the menstrual cycle and during pregnancy. Hyperventilation
during pregnancy is important in increasing the Po2 in
maternal arterial blood, thus allowing better oxygenation of
the fetus. This mechanism illustrates how the endocrine and
nervous systems can interact to regulate a vital body func-
tion.
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